Parminder Ruprah, Head of Chemistry

Parminder has over 20 years of experience in project leadership and management of all aspects drug discovery and, in particular, medicinal chemistry in CNS diseases and oncology. 

Parminder has major pharma experience including Pfizer, Millenium and Takeda where she was Senior Group Leader in medicinal chemistry leading teams on GPCR and enzyme targets in CNS and IBD.  This is complemented by experience of leadership of medicinal chemistry and consultancy at biotech companies including Amedis and Paradigm Therapeutics.

Parminder holds a PhD in organic chemistry from the University of Bath and a BSc in Chemistry.

“Kuano’s quantum and AI platform results in better candidates earlier in the drug discovery process, and de-risks in vivo and clinical stages. In contrast to competing methods, our approach does not require access to large amounts of experimental data, which together with our quantum driven design approach provides transformational  access to valuable first-in-class targets.”